be challenged. Currently‚ many firms sought to overcome their lack of experience in marketing consumer products through alliances of various forms—mergers‚ joint ventures‚ or licensing agreements. Pepcid‚ Tagamet and Zantac are among the most successful prescription drugs ever marketed. Pepcid is ranked in the top 15 largest-selling prescription products with 18 million U.S. prescriptions written since its prescription debut in 1986. However‚ those numbers pale in comparison to Tagamet and Zantac
Premium Food and Drug Administration Pharmacology
The problem Pepcid AC faced in its initial entry into the market was direct competition from competing products that‚ together‚ took almost all market share. Pepcid AC positioned itself as three important things: providing lasting relief from GERD and gastrointestinal upset by means of the fewest pills possible and providing not only relief but prevention. Tegamet already had an established marketing base that consisted of customers who knew the brand name and were weary to switch to another product
Premium Marketing Competition Advertising
Thoma Bravo – Citect Corporation (HBS 9-209-022) Study Questions 1. Do you think TB or Schneider would create more value as the owner of Citect? 2. TB would assume what risks if they are the winning bidder? 3. Should TB continue to bid on Citect and at what price? Are the expected ROIs and IRRs to TB sufficient at your revised bid amount? (* note: a detailed evaluation model will be constructed during the class session *) Study Questions 1. Is Newell just another conglomerate? How
Premium Discounted cash flow Price Norfolk Southern Railway
1- Introduction Developed and commercialized by Merck‚ Pepcid is a prescription drug for treatment of heartburn. Different from regular antacids that just neutralize acids in the stomach‚ Pepcid belongs to a class of drugs known as H2 receptor antagonists‚ which reduce stomach acid secretion by blocking the histamine H2-receptor on the cells producing gastric acid. Third in the H2’s class to enter the prescription drugs market‚ Pepcid was never able to reverse course and take market leadership from
Premium Gastroesophageal reflux disease Peptic ulcer Food and Drug Administration
March 1989 Merck and Johnson & Johnson joined hands to form the joint venture Johnson & Johnson/Merck Consumer Pharmaceuticals Company (JJM). JJM produces Pepcid which belongs to a class of drugs known as H2 receptor antagonists. This class of drugs reduces stomach acid secretion and revolutionized the treatment for ulcers and heartburn. Pepcid is well known for its quick heartburn relief has a stable market position but is still behind the leading competitors Tagamet (from SmithKline Beecham) and
Premium Food and Drug Administration Pharmacology Prescription drug
Case: Land Securities Group (A): Choosing Cost or Fair Value on Adoption of IFRS Case Number: 9-105-014 Topic: Financial Reporting and Control Description: A U.K. real estate firm‚ required to adopt international accounting standards (IAS) by 2005‚ must change the reporting of its primary asset (investment property) from the revaluation model under U.K. GAAP to either the cost or fair-value model under IAS. This would have a number of effects on European investment property firms‚ including
Premium Financial statements International Financial Reporting Standards Finance
2010 [Type text] Emerging Company Finance FNCE 480 - Final Frank Kurupacheril [TRENDSETTER’S TWO ROADS] Trendsetter‚ Inc – a warehouse and distribution solution software company for clothing retailers is faced with the usual dilemma. They are running out of seed money that the founders contributed. Now they have received two term sheets from prospective VC’s. The ball is in the founders’ court who have to choose one after weighing pros and the cons. Contents Introduction .
Premium Stock Stock market Venture capital
MBA 560 – Marketing Principles Case Analysis Pepcid AC Racing to the OTC Market The managers at Johnson & Johnson/Merck Consumer Pharmaceuticals Co. (JJM) have two options regarding their newest over-the-counter (OTC) drug Pepcid AC. The first option would be to pursue both claims of treatment and prevention‚ which would help differentiate their drug from other competitors OTC drugs that are also pending FDA approval. The first option could require up to 9 months of additional studies
Premium Marketing Strategic management Management
Case Analysis Saku Problem Synopsis of the Situation Saku offers products in six different product categories. Some of their products are doing well while sales of some products are declining. Certain segments are experiencing market growth while some others are close to stagnation. The company wants to determine a product portfolio for the next few years that will take advantage of opportunities for expansion without negatively impacting the current sales of its products. Key Issues
Premium Marketing Soft drink
FINS5530 HBS Case Assignment Semester 2‚ 2013 Instructor: Lixiong Guo Readings: 1. Note on Bank Loans. 2. US Bank of Washington case. Assignment: Please prepare a Credit Proposal Memo similar to the one shown in Exhibit 1 of “Note on Bank Loans”. Given the limited information you have from the case‚ you are not expected to include all components of Exhibit 1. The following is a suggested structure of your report: Purpose of the credit extension o Keep this part short
Premium Loan Debt Cash flow